PT-141 Bremelanotide 10mg - Lyophilised Research Peptide Vial
Peptide Research

PT-141 (Bremelanotide) 10mg

AUD $150

Aurelia Bio PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist analogue supplied for analytical, laboratory, and preclinical research applications. Each unit contains 10mg per vial prepared for research handling consistency.

PT-141 is referenced in melanocortin receptor research where controlled lyophilised material, clear quantity, and batch documentation help maintain consistent study parameters.

Supplied strictly for research use only. Not for human or animal consumption, and not intended for therapeutic, diagnostic, or clinical use.

Quantity10mg per vial
FormLyophilised Powder
PurityBatch Verification Available
VerificationBatch-Specific COA
ShippingAustralia-Wide
UsageResearch Only